Holen Sie sich die Stockscreener-App
0.8871
1.97%
-0.0178
Handel nachbörslich:
.90
0.0129
+1.45%
Schlusskurs vom Vortag:
$0.9049
Offen:
$0.8905
24-Stunden-Volumen:
159.95K
Relative Volume:
0.98
Marktkapitalisierung:
$33.78M
Einnahmen:
$24.38M
Nettoeinkommen (Verlust:
$-53.95M
KGV:
-0.3591
EPS:
-2.47
Netto-Cashflow:
$-23.31M
1W Leistung:
+1.19%
1M Leistung:
-30.70%
6M Leistung:
-55.87%
1J Leistung:
-76.28%
1-Tages-Spanne:
$0.87
$0.90
1-Wochen-Bereich:
$0.87
$0.9999
52-Wochen-Spanne:
$0.85
$5.12
Elutia Inc Stock (ELUT) Company Profile
Firmenname
Elutia Inc
Sektor
Branche
Telefon
240-247-1143
Adresse
12510 PROSPERITY DRIVE, SILVER SPRING
Vergleichen Sie ELUT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELUT
Elutia Inc
|
0.8871 | 38.36M | 24.38M | -53.95M | -23.31M | -2.47 |
|
ABT
Abbott Laboratories
|
133.27 | 228.66B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
96.24 | 140.69B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
370.00 | 139.51B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
96.54 | 122.60B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.36 | 42.83B | 5.69B | 1.41B | 577.90M | 6.9828 |
Elutia Inc Stock (ELUT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-11-02 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-11-02 | Eingeleitet | Cowen | Outperform |
| 2020-11-02 | Eingeleitet | Piper Sandler | Overweight |
| 2020-11-02 | Eingeleitet | Truist | Buy |
Elutia Inc Aktie (ELUT) Neueste Nachrichten
Is Elutia Inc. stock a buy before product launchesEarnings Risk Report & Low Risk Profit Maximizing Plans - newser.com
Relative strength of Elutia Inc. in sector analysisJuly 2025 Retail & Weekly Momentum Picks - newser.com
How Elutia Inc. stock benefits from global expansionTrade Analysis Report & Daily Volume Surge Signals - newser.com
Analyzing Elutia Inc. with risk reward ratio chartsJuly 2025 Weekly Recap & Weekly Breakout Stock Alerts - newser.com
Chart based exit strategy for Elutia Inc.July 2025 Earnings & Expert Verified Movement Alerts - newser.com
Risk vs reward if holding onto Elutia Inc.Trade Analysis Report & Verified Stock Trade Ideas - newser.com
Chart overlay techniques for tracking Elutia Inc.Quarterly Portfolio Review & Fast Gaining Stock Reports - newser.com
How Elutia Inc. stock performs in high volatility marketsWeekly Profit Analysis & Free Weekly Chart Analysis and Trade Guides - newser.com
How Elutia Inc. stock responds to policy changesWeekly Trend Recap & Verified Stock Trade Ideas - newser.com
The Market Doesn't Like What It Sees From Elutia Inc.'s (NASDAQ:ELUT) Revenues Yet As Shares Tumble 30% - simplywall.st
Elutia appoints medical tech veteran Guido Neels to board of directors - Investing.com Nigeria
Elutia Completes Sale of BioEnvelope to Boston Scientific - MSN
Applying big data sentiment scoring on Elutia Inc.Quarterly Earnings Report & Low Risk High Reward Trade Ideas - newser.com
Elutia Appoints Guido J. Neels To Board - citybiz
Elutia Appoints Accomplished MedTech Veteran Guido J. Neels to Board of Directors - The Manila Times
Elutia Inc. Appoints Guido J. Neels to Board of Directors, Strengthening Leadership in Medical Technology - Quiver Quantitative
Elutia appoints accomplished medtech veteran Guido J. Neels to board of directors - MarketScreener
Elutia Appoints Accomplished MedTech Veteran Guido J. Neels To Board Of Directors - TradingView
Elutia Inc. (NASDAQ:ELUT) Just Reported, And Analysts Assigned A US$6.50 Price Target - 富途牛牛
When is the best time to exit Elutia Inc.2025 Trading Volume Trends & Precise Trade Entry Recommendations - newser.com
Backtesting results for Elutia Inc. trading strategies2025 Technical Overview & Real-Time Market Sentiment Alerts - newser.com
What MACD signals say about Elutia Inc.2025 EndofYear Setup & Safe Swing Trade Setups - newser.com
Using portfolio simulators with Elutia Inc. includedMarket Growth Review & Detailed Earnings Play Strategies - newser.com
Combining machine learning predictions for Elutia Inc.Layoff News & Risk Controlled Stock Pick Alerts - newser.com
Tools to monitor Elutia Inc. recovery probabilityWatch List & High Accuracy Swing Entry Alerts - newser.com
Medical Device Innovator: Michelle LeRoux Williams - The Business Journals
SWK Holdings announces full repayment of Elutia loan following asset sale - Investing.com Canada
SWK Holdings announces full repayment of Elutia loan following asset sale By Investing.com - Investing.com Nigeria
Boston Sci closes Elutia deal, projects 10% growth through 2028 - BioWorld MedTech
SWK Holdings Announces Full Loan Repayment by Elutia - TipRanks
Elutia Closes BioEnvelope Business Sale To Boston Scientific For $88 Million - citybiz
Elutia announces closing of BioEnvelope business sale to Boston Scientific Corporation - MarketScreener
Elutia Announces Closing Of Bioenvelope Business Sale To Boston Scientific Corporation - TradingView
Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million - The Manila Times
Elutia Inc. Completes $88 Million Sale of BioEnvelope Business to Focus on NXT-41x Development for Breast Reconstruction - Quiver Quantitative
Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million - Benzinga
$88M Deal: Elutia Sells BioEnvelope to Boston Scientific, Targets $1.5B Breast Reconstruction Market - Stock Titan
Elutia (NASDAQ:ELUT) Stock Price Down 6.3% – Should You Sell? - Defense World
Finanzdaten der Elutia Inc-Aktie (ELUT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Elutia Inc-Aktie (ELUT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| HighCape Capital, L.P. | Director |
Feb 03 '25 |
Buy |
2.50 |
420,000 |
1,050,000 |
9,520,232 |
1.19%
1.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):